![Soumya CHAKRAVARTY | Senior Director & Strategic Lead Rheumatology Therapeutic Area | MD PhD | Immunology Medical Affairs | Research profile Soumya CHAKRAVARTY | Senior Director & Strategic Lead Rheumatology Therapeutic Area | MD PhD | Immunology Medical Affairs | Research profile](https://i1.rgstatic.net/ii/profile.image/1093910050947077-1637819888582_Q512/Soumya-Chakravarty.jpg)
Soumya CHAKRAVARTY | Senior Director & Strategic Lead Rheumatology Therapeutic Area | MD PhD | Immunology Medical Affairs | Research profile
Goldman Sachs' new managing-director list is out — and it's the largest class in the firm's history (GS)
![Full covariate modelling approach in population pharmacokinetics: understanding the underlying hypothesis tests and implications of multiplicity - Xu - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library Full covariate modelling approach in population pharmacokinetics: understanding the underlying hypothesis tests and implications of multiplicity - Xu - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/ac25cb6c-f013-4f0b-8485-37cf04a45427/bcp.v84.7.cover.jpg?trick=1680418500194)
Full covariate modelling approach in population pharmacokinetics: understanding the underlying hypothesis tests and implications of multiplicity - Xu - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library
![Full covariate modelling approach in population pharmacokinetics: understanding the underlying hypothesis tests and implications of multiplicity - Xu - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library Full covariate modelling approach in population pharmacokinetics: understanding the underlying hypothesis tests and implications of multiplicity - Xu - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/ff26a92c-2539-4ca9-bb61-571c1185ee22/bcp13577-fig-0002-m.jpg)
Full covariate modelling approach in population pharmacokinetics: understanding the underlying hypothesis tests and implications of multiplicity - Xu - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library
![Daratumumab (DARA) Subcutaneous (SC) Delivery in Relapsed or Refractory Multiple Myeloma (RRMM): Population Pharmacokinetics (PPK) and Exposure-Response (E-R) Analysis - ScienceDirect Daratumumab (DARA) Subcutaneous (SC) Delivery in Relapsed or Refractory Multiple Myeloma (RRMM): Population Pharmacokinetics (PPK) and Exposure-Response (E-R) Analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497118610808-gr1.jpg)
Daratumumab (DARA) Subcutaneous (SC) Delivery in Relapsed or Refractory Multiple Myeloma (RRMM): Population Pharmacokinetics (PPK) and Exposure-Response (E-R) Analysis - ScienceDirect
![Diagnostics | Free Full-Text | Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy Diagnostics | Free Full-Text | Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy](https://pub.mdpi-res.com/diagnostics/diagnostics-12-02091/article_deploy/html/images/diagnostics-12-02091-g001.png?1661933155)
Diagnostics | Free Full-Text | Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy
![Steven JANSEN | Professor (Full) | PhD | Ulm University, Ulm | UULM | Institute of Systematic Botany and Ecology | Research profile Steven JANSEN | Professor (Full) | PhD | Ulm University, Ulm | UULM | Institute of Systematic Botany and Ecology | Research profile](https://i1.rgstatic.net/ii/profile.image/272202771726352-1441909606362_Q512/Steven-Jansen-3.jpg)
Steven JANSEN | Professor (Full) | PhD | Ulm University, Ulm | UULM | Institute of Systematic Botany and Ecology | Research profile
![PDF) Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes PDF) Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes](https://i1.rgstatic.net/publication/221745491_Population_pharmacokinetics_and_pharmacodynamics_of_rivaroxaban_in_patients_with_acute_coronary_syndromes/links/5bfcb795a6fdcc76e722b770/largepreview.png)